
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
For nearly 40 years, Carolyn Glynn has risen through the ranks in Roche’s public affairs department. Even more difficult than representing the company to the outside world, she says, was championing outside constituents inside the company to give them a voice.






